Literature DB >> 21126699

The refluxate: The impact of its magnitude, composition and distribution.

Philip Woodland1, Daniel Sifrim.   

Abstract

The pathogenesis of gastrointestinal reflux disease is multifactoral. Integral to the disease process is the refluxate itself. The characteristics and composition of the refluxate are dependent on several physiological variables. The refluxate may contain varying concentrations of acid, pepsin, gas, or contents of duodenal reflux (such as bile acid and pancreatic enzymes). Characteristics such as volume and proximal extent of the refluxate, and the chemical content of this refluxate can strongly influence the risk of symptom perception. Strong acid (pH<4) and duodeno-gastro-oesophageal reflux are also implicated in the development of mucosal damage in the form of oesophagitis, Barrett's metaplasia and oesophageal adenocarcinoma. The manifestation of disease, however, is not entirely reliant on the refluxate, which must be considered in the context of the genetic, environmental and psychological susceptibility of the individual.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126699     DOI: 10.1016/j.bpg.2010.09.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  7 in total

Review 1.  Esophageal testing: What we have so far.

Authors:  Nicola de Bortoli; Irene Martinucci; Lorenzo Bertani; Salvatore Russo; Riccardo Franchi; Manuele Furnari; Salvatore Tolone; Giorgia Bodini; Valeria Bolognesi; Massimo Bellini; Vincenzo Savarino; Santino Marchi; Edoardo Vincenzo Savarino
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 2.  Barrett's esophagus in 2016: From pathophysiology to treatment.

Authors:  Irene Martinucci; Nicola de Bortoli; Salvatore Russo; Lorenzo Bertani; Manuele Furnari; Anna Mokrowiecka; Ewa Malecka-Panas; Vincenzo Savarino; Edoardo Savarino; Santino Marchi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

3.  Nocturnal gastroesophageal reflux revisited by impedance-pH monitoring.

Authors:  Fernando Fornari; Kathleen Blondeau; Veerle Mertens; Jan Tack; Daniel Sifrim
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

Review 4.  Symptomatic reflux disease: the present, the past and the future.

Authors:  Guy Boeckxstaens; Hashem B El-Serag; André J P M Smout; Peter J Kahrilas
Journal:  Gut       Date:  2014-03-07       Impact factor: 23.059

5.  Republished: symptomatic reflux disease: the present, the past and the future.

Authors:  Guy Boeckxstaens; Hashem B El-Serag; André J P M Smout; Peter J Kahrilas
Journal:  Postgrad Med J       Date:  2015-01       Impact factor: 2.401

Review 6.  Antacids revisited: review on contemporary facts and relevance for self-management.

Authors:  Vandana Garg; Prashant Narang; Ritu Taneja
Journal:  J Int Med Res       Date:  2022-03       Impact factor: 1.671

7.  Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON).

Authors:  Michael B Cook; Douglas A Corley; Liam J Murray; Linda M Liao; Farin Kamangar; Weimin Ye; Marilie D Gammon; Harvey A Risch; Alan G Casson; Neal D Freedman; Wong-Ho Chow; Anna H Wu; Leslie Bernstein; Olof Nyrén; Nirmala Pandeya; David C Whiteman; Thomas L Vaughan
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.